Media Center Found (699)
Array ( [cache_time] => 0 [counts_time] => 0.0060901641845703 [query_time] => 0.0047149658203125 [total_time] => 0.010805130004883 )
July 26, 2007

Prof. Naftali Tishby dreams of the day when we will be able transfer a copy of our souls onto the computer before our death so that the soul will continue to think, feel, and answer our grandchildren's questions long after our bodies...

More
July 25, 2007

The French-Israeli eye drug maker uses technology developed by the Hebrew University of Jerusalem.

More
June 24, 2007

Jerusalem Development Authority allocates initial 10 million NIS to BioJerusalem

More
June 21, 2007

Reinventing the wheel- the latest car technology on the Wall Street Journal

More
June 11, 2007

Peter Stern, Senior Editor, Science Magazine, speaks with Globes of fascinating theories of brain research at Yissum's luncheon, at Biomed 2007

More
June 6, 2007

A Hebrew University doctoral student who is the first cousin of the president of Chile has won a prestigious research prize for developing a "knockout technique" in special "antibody nose drops" against allergies that he tested successfully on...

More
June 4, 2007

Commercial aspects of the transfer of academic research to the pharmaceutical industry

More
May 28, 2007

As a Gold sponsor, we are pleased to invite you to visit our booth (no 24), which will be located at the entrance to the main exhibition hall

More
May 24, 2007

Nava Swersky Sofer isn't the type of person to look back at her accomplishments and congratulate herself. Instead, she says, she's a forward thinker who focuses keenly on her next move. 

More
April 17, 2007

Tiltan attacks cancer using four different materials 

 

More
April 12, 2007

The company has developed a method for applying transgenic tobacco to produce human recombinant collagen.

More
April 11, 2007

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

More
April 10, 2007

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

More
April 5, 2007

Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis

 

More
April 4, 2007

Four years after the first information on featherless broiler research was known, the attention of the public and world media was attracted. Commercial trials show the big advantage over their feathered relatives, especially when kept in tropical...

More
March 25, 2007

Bioline will develop a new drug based on the technology of Prof. Hillel Bercovier and Dr. Ayelet Barenholz of the Hebrew university. 

 

More
February 28, 2007

The agreement is reportedly worth several million dollars. 

 

More
January 30, 2007

Yissum subsidiary Target-In and Indian company Century Pharmaceuticals will jointly develop a new drug for asthma and allergy, which will be based on the molecule developed by the Israel company.  

(Hebrew article attached)

More